|
241. Taqman or SYBR? - (reply: 4)
242. Overcoming PCR bias before bisulfite sequencing?! - (reply: 2)
243. primer flaw I'm missing? - (reply: 7)
244. MSP Primer design -rules to choose primers and reasons - (reply: 2)
245. aza treatment p16 - (reply: 5)
246. Filamentous pellet when you sonicate in ChIP assay - (reply: 2)
247. solid support for ChIP washes - (reply: 7)
248. ChIP tag, Flag or HA sequence - (reply: 3)
249. dissociation curve converted dna - (reply: 1)
250. Why are CpG sites more prone to mutation? - (reply: 4)
251. How to interprete direct sequencing results? - (reply: 26)
252. pGEM methylation status - (reply: 6)
253. Bisulfite modification of DNA from paraffin embedded tissue - (reply: 4)
254. QPCR with MSP - (reply: 3)
255. New to area - (reply: 3)
256. Companies for ChIP Ab - (reply: 2)
257. ChIP IgG has the same signal than the antibody tested - (reply: 9)
258. Why should it be digested with a restriction enzyme before treated with bisulfi - (reply: 5)
259. Controls in ChIP experiments? - (reply: 5)
260. Best Chromatin IP antibody?(tag) - (reply: 3)
261. Does aza affect DNA/RNA quality? - (reply: 6)
262. MSP primer design - understanding the basics - (reply: 2)
263. pyrosequencing question - (reply: 2)
264. Bisulfite: PCR condition or primer problem? - (reply: 13)
265. Inbreeding - (reply: 1)
266. SDS Precipitation with 1% Lysis Buffer after 10' on ice - (reply: 1)
267. RNA - (reply: 1)
268. Nanog Methylation and sequencing - (reply: 3)
269. Preferential methylation of specific CpG sites? - (reply: 9)
270. Bisulfite sequencing of PCR products after AIMS technique - (reply: 3)
242. Overcoming PCR bias before bisulfite sequencing?! - (reply: 2)
243. primer flaw I'm missing? - (reply: 7)
244. MSP Primer design -rules to choose primers and reasons - (reply: 2)
245. aza treatment p16 - (reply: 5)
246. Filamentous pellet when you sonicate in ChIP assay - (reply: 2)
247. solid support for ChIP washes - (reply: 7)
248. ChIP tag, Flag or HA sequence - (reply: 3)
249. dissociation curve converted dna - (reply: 1)
250. Why are CpG sites more prone to mutation? - (reply: 4)
251. How to interprete direct sequencing results? - (reply: 26)
252. pGEM methylation status - (reply: 6)
253. Bisulfite modification of DNA from paraffin embedded tissue - (reply: 4)
254. QPCR with MSP - (reply: 3)
255. New to area - (reply: 3)
256. Companies for ChIP Ab - (reply: 2)
257. ChIP IgG has the same signal than the antibody tested - (reply: 9)
258. Why should it be digested with a restriction enzyme before treated with bisulfi - (reply: 5)
259. Controls in ChIP experiments? - (reply: 5)
260. Best Chromatin IP antibody?(tag) - (reply: 3)
261. Does aza affect DNA/RNA quality? - (reply: 6)
262. MSP primer design - understanding the basics - (reply: 2)
263. pyrosequencing question - (reply: 2)
264. Bisulfite: PCR condition or primer problem? - (reply: 13)
265. Inbreeding - (reply: 1)
266. SDS Precipitation with 1% Lysis Buffer after 10' on ice - (reply: 1)
267. RNA - (reply: 1)
268. Nanog Methylation and sequencing - (reply: 3)
269. Preferential methylation of specific CpG sites? - (reply: 9)
270. Bisulfite sequencing of PCR products after AIMS technique - (reply: 3)